- Home
- / AmbioPharm
AmbioPharm
Total Funding
$24 M
AmbioPharm Summary
Company Summary
- Overview
- AmbioPharm is a peptide development and manufacturing company. It provides good manufacturing practice (GMP), analytical development and validation, vaccine, cosmetic peptide development, and other services. The company serves biotechnology and pharmaceutical companies as well as clinical research labs.
- Type
- Private
- Status
- Active
- Founded
- 2005
- HQ
- Beech Island, SC, US | view all locations
- Website
- https://www.ambiopharm.com/
- Cybersecurity rating
Table of Contents
Key People
Brian Gregg, Chief Executive Officer
Mike Pennington, Chief Scientific Officer
Stephen John Kiel, Chief Financial Officer
Operating MetricsView all
Trademarks (US)
2
Feb, 2022
Manufacturing Facilities (United States)
82.6K
Feb, 2022
Manufacturing Facilities (China)
26.5K
Feb, 2022
LocationsView all
2 locations detected
Beech Island, SC HQ
United States
1024 Dittman Ct
Shanghai, Shanghai
China
No.399, Yingong Road, Fengxian Sub-zone, Shanghai Chemical Industry Park